Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 2/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22199053 | 0.92 | PDCD1 (0.47) | PDCD1CD274ALKBH5FTOKDM4E | |
| SCHEMBL24848725 | 0.88 | ALKBH5 (0.47) | DUSP3ALKBH5FTOKDM4EATM | |
| SCHEMBL22199407 | 0.87 | PDCD1 (0.35) | PDCD1CD274DUSP3ALKBH5FTO | |
| SCHEMBL26254026 | 0.87 | PDCD1 (0.35) | PDCD1CD274DUSP3ALKBH5FTO | |
| SCHEMBL17902070 | 0.87 | KDM4E (0.48) | DUSP3ALKBH5FTOKDM4EATM | |
| SCHEMBL26254029 | 0.86 | DUSP3 (0.37) | PDCD1CD274DUSP3ALKBH5FTO | |
| SCHEMBL19269413 | 0.85 | L3MBTL1 (0.41) | PDCD1CD274KDM4EATML3MBTL1 | |
| SCHEMBL19269274 | 0.85 | L3MBTL1 (0.41) | PDCD1CD274KDM4EATML3MBTL1 | |
| SCHEMBL29089282 | 0.83 | MAPT (0.41) | PDCD1CD274DUSP3ALKBH5FTO | |
| SCHEMBL12447618 | 0.83 | POLB (0.44) | DUSP3KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287011-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230002417-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287011-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OXGR1, OCIAD1 | PDCD1 588/4885CD274 246/4885DUSP3 3799/4885 |
| US-20230002417-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ODC1 | PDCD1 1001/4885CD274 1213/4885DUSP3 4668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.